Commonwealth Coat of Arms of Australia

 

National Health (Pharmaceutical Benefits)

(Pharmacist Substitution of Medicines without

Prescription during Shortages) Amendment (No. 4) Determination 2024

I, Eden Simon, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated    14 November 2024

 

 

 

 

 

Eden Simon

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 

 

Contents

1 Name

2 Commencement

3 Authority

4 Schedules

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021

1  Name

  1.     This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 4) Determination 2024.
  2.     This instrument may also be cited as PB 122 of 2024.

2  Commencement

  1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

 

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

19 November 2024

19 November 2024

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

  1.     Any information in column 3 of the table is not part of this instrument.

Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of

Medicines without Prescription during Shortages) Determination 2021

1  Subsection 5(8)

 

Repeal the table, substitute:

Prescribed and substitute pharmaceutical benefits

Item

Column 1
Prescribed pharmaceutical benefit

Column 2
Substitute pharmaceutical benefit

1

Listed drug:  Insulin degludec with insulin aspart

Form:   Injections, prefilled pen, 70 units30 units per mL, 3 mL, 5

Manner of administration: Injection

Brand:  Ryzodeg Flextouch

Listed drug:  Insulin degludec with insulin aspart

Form:   Injections, cartridges, 70 units30 units per mL, 3 mL, 5

Manner of administration: Injection

Brand:  Ryzodeg Penfill

2

Listed drug: Estradiol

Form: Transdermal patches 390 micrograms, 8

Manner of administration: Transdermal

Brand:  Estradot 25

 

Listed drug: Estradiol

Form: Transdermal patches 750 micrograms (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 25

 

3

Listed drug: Estradiol

Form: Transdermal patches 750 micrograms (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 25

Listed drug: Estradiol

Form: Transdermal patches 390 micrograms, 8

Manner of administration: Transdermal

Brand:  Estradot 25

 

4

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand:  Estradot 50

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 50

 

5

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand:  Estradot 50

Listed drug: Estradiol

Form: Transdermal patches 390 micrograms, 8

Manner of administration: Transdermal

Brand: Estradot 25

6

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand:  Estradot 50

Listed drug: Estradiol

Form: Transdermal patches 750 micrograms (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 25

7

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 50

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand: Estradot 50

8

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 50

Listed drug: Estradiol

Form: Transdermal patches 390 micrograms, 8

Manner of administration: Transdermal

Brand: Estradot 25

9

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 50

Listed drug: Estradiol

Form: Transdermal patches 750 micrograms (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 25

10

Listed drug: Estradiol

Form: Transdermal patches 1.17 mg, 8

Manner of administration: Transdermal

Brand:   Estradot 75

Listed drug: Estradiol

Form: Transdermal patches 585 micrograms, 8

Manner of administration: Transdermal

Brand: any of the following:

(a) Estradot 37.5

(b) Estradiol Transdermal System (Sandoz, USA)

11

Listed drug: Estradiol

Form: Transdermal patches 1.56 mg, 8

Manner of administration: Transdermal

Brand:   Estradot 100

Listed drug: Estradiol

Form: Transdermal patches 3 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 100

12

Listed drug: Estradiol

Form: Transdermal patches 1.56 mg, 8

Manner of administration: Transdermal

Brand:   Estradot 100

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand: Estradot 50

13

Listed drug: Estradiol

Form: Transdermal patches 1.56 mg, 8

Manner of administration: Transdermal

Brand:   Estradot 100

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 50

14

Listed drug: Estradiol

Form: Transdermal patches 3 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 100

Listed drug: Estradiol

Form: Transdermal patches 1.56 mg, 8

Manner of administration: Transdermal

Brand: any of the following:

(a) Estradot 100

(b) Estradiol Transdermal System (Sandoz, USA)

15

Listed drug: Estradiol

Form: Transdermal patches 3 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 100

Listed drug: Estradiol

Form: Transdermal patches 780 micrograms, 8

Manner of administration: Transdermal

Brand: Estradot 50

16

Listed drug: Estradiol

Form: Transdermal patches 3 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand:   Estraderm MX 100

Listed drug: Estradiol

Form: Transdermal patches 1.5 mg (as hemihydrate), 8

Manner of administration: Transdermal

Brand: Estraderm MX 50